[{"NetIncomeLoss_2_Q2_USD":-38475000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":86282000.0,"Depreciation_1_Q2_USD":2300000.0,"Depreciation_2_Q2_USD":4500000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":29090000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":179000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-100000.0,"InterestPaidNet_2_Q2_USD":10000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":86282000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":1729000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q2_USD":9253000.0,"CommitmentsAndContingencies_0_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":400000.0,"DueFromRelatedPartiesCurrent_0_Q2_USD":26000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":98769687.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":98621161.0,"OperatingLeaseLiability_0_Q2_USD":12555000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":7449000.0,"StockRepurchasedAndRetiredDuringPeriodShares_1_Q2_shares":0.0,"StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0_Q2_USD":18300000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":3671000.0,"CommonStockSharesIssued_0_Q2_shares":107764158.0,"IncomeTaxesPaidNet_2_Q2_USD":4000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":5000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":28000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3754000.0,"DueToRelatedPartiesCurrent_0_Q2_USD":2228000.0,"FinanceLeaseInterestExpense_1_Q2_USD":3000.0,"InsuranceSettlementsReceivableCurrent_0_Q2_USD":0.0,"FinanceLeaseInterestExpense_2_Q2_USD":10000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":564000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":564000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":5097068.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":6519000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":11892000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":14790000.0,"AssetsCurrent_0_Q2_USD":115287000.0,"AccruedSalariesCurrent_0_Q2_USD":1304000.0,"StockRepurchasedAndRetiredDuringPeriodShares_2_Q2_shares":0.0,"Liabilities_0_Q2_USD":26511000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":870408000.0,"Revenues_1_Q2_USD":1000.0,"Revenues_2_Q2_USD":22000.0,"CommonStockValue_0_Q2_USD":11000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1_Q2_USD":29000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_2_Q2_USD":5000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q2_USD":-48000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":-93000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":4000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":67000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":99000.0,"AccruedBonusesCurrent_0_Q2_USD":3105000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":14950000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":13709000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":26943000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-167000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":4000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q2_USD":0.0,"InvestmentIncomeNet_1_Q2_USD":75000.0,"InvestmentIncomeNet_2_Q2_USD":253000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":9462000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":102698000.0,"OtherAssetsNoncurrent_0_Q2_USD":2602000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-20064000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-38470000.0,"OtherAssetsCurrent_0_Q2_USD":67000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":44420000.0,"PrepaidRent_0_Q2_USD":414000.0,"ImpairmentOfInvestments_1_Q2_USD":0.0,"ImpairmentOfInvestments_2_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":0.0,"RealizedInvestmentGainsLosses_1_Q2_USD":1000.0,"RealizedInvestmentGainsLosses_2_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":87217000.0,"IncreaseDecreaseInDueToRelatedPartiesCurrent_2_Q2_USD":386000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":4484000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":1083000.0,"Assets_0_Q2_USD":196164000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2168000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":5000.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":5000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":87190000.0,"LiabilitiesCurrent_0_Q2_USD":17049000.0,"ProceedsFromWarrantExercises_2_Q2_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-29117000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":316000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":761000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":163000.0,"AccountsPayableCurrent_0_Q2_USD":3971000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-20088000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":23068000.0,"PaymentsToAcquireEquityMethodInvestments_2_Q2_USD":0.0,"CommonStockSharesOutstanding_0_Q2_shares":107764158.0,"AssetImpairmentCharges_2_Q2_USD":0.0,"OtherSundryLiabilitiesCurrent_0_Q2_USD":58000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_2_Q2_USD":-163000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_1_Q2_USD":-40000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-38471000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-700666000.0,"NonoperatingIncomeExpense_2_Q2_USD":342000.0,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_2_Q2_pure":0.0,"NetIncomeLoss_1_Q2_USD":-20092000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":58615000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":2131000.0,"PrepaidInsurance_0_Q2_USD":189000.0,"OperatingLeasePayments_1_Q2_USD":1100000.0,"OperatingLeasePayments_2_Q2_USD":2100000.0,"OtherAssetsMiscellaneousNoncurrent_0_Q2_USD":21000.0,"NonoperatingIncomeExpense_1_Q2_USD":139000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":102877000.0,"SecurityDeposit_0_Q2_USD":113000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.09,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":75000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":564000.0,"ProceedsFromStockOptionsExercised_1_Q2_USD":600000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4664000.0,"StockIssued1_2_Q2_USD":0.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-91000.0,"RestrictedCashAndCashEquivalents_0_Q2_USD":179000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":540000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_Q2_USD":1471000.0,"OperatingIncomeLoss_1_Q2_USD":-20227000.0,"OperatingIncomeLoss_2_Q2_USD":-38813000.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-927000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2545000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":2395000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":0.0,"DueToCorrespondentBrokers_0_Q2_USD":250000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_2_Q2_USD":0.0,"InterestReceivableCurrent_0_Q2_USD":113000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":86816000.0,"DebtConversionConvertedInstrumentAmount1_2_Q2_USD":0.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":10407000.0,"ShareBasedCompensation_2_Q2_USD":761000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1_Q2_USD":1000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":7925000.0,"InvestmentIncomeInterest_2_Q2_USD":346000.0,"InvestmentIncomeInterest_1_Q2_USD":122000.0,"StockholdersEquity_0_Q2_USD":169653000.0,"OtherLiabilitiesCurrent_0_Q2_USD":3401000.0,"DeferredOfferingCosts_0_Q2_USD":534000.0,"LitigationSettlementAmountAwardedToOtherParty_2_Q2_USD":12000000.0,"ProfitLoss_2_Q2_USD":-38475000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.2,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.39,"OperatingExpenses_1_Q2_USD":20228000.0,"OperatingExpenses_2_Q2_USD":38835000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3093000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q2_USD":0.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":81683000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q2_USD":0.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_2_Q2_USD":0.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":761000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":316000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":196164000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":28000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1102000.0,"Ticker":"IBRX","CIK":"1326110","name":"NANTKWEST, INC.","OfficialName":"ImmunityBio Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"1985576569.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20200807"}]